Epidemiological studies have taken advantage of a number of strategies to monitor human populations for mortality, incidence, and exposure to hazardous environmental agents. These studies have been compromised by the lack of individual exposure assessment data that precisely quantifies internal dose. As methods improve in analytical chemistry and molecular biology, direct biological monitoring of exposed populations is possible. Biomarkers 479-483 (1996) 
effects. This method obviously is less precise in estimating health outcomes than using specific measurement of individual exposure doses in human effects studies.
Historically, epidemiological studies have taken advantage of a number of strategies to monitor human populations for disease occurrence and exposure to hazardous toxicants. As early as the 1800s, reviews of death certificates were used to describe the disease burden to populations and to attempt to attribute lifestyle factors or social ills to mortality. Communicable disease reporting is also an example of monitoring the population for a variety of contagious diseases. The Centers for Disease Control require physicians to report selected communicable diseases to monitor the levels of pathogens and viruses in the population. This reporting system is used to target susceptible subpopulations for immunization programs, to institute preventive programs such as rabies vaccinations, and to help identify new emerging microbes such as the hantavirus. Human population monitoring for chronic diseases is also widespread in developed countries. Scandinavian countries have developed a unique resource for human population monitoring by linking health insurance identification numbers, census data, and different hospital databases to create disease registries. Cancer and birth defect registries and other such surveillance systems have been used extensively in these countries to study trends of incidence, mortality, and health care utilization as well as to launch many noted epidemiological studies of disease etiology (1, 2) . In the United States, the SEER (Surveillance, Epidemiology, and End Results) network provides a geographically diverse set of population-based registries to monitor the occurrence of cancer across the United States. Many states have cancer and birth defects registries that vary in coverage and quality from hospital-based reporting to population surveillance. Systems (4) .
Exposure Assessment
Assessing human exposure to chemicals, especially from Superfund sites, requires not only understanding and applying knowledge from a number of scientific disciplines but also the gathering of large amounts of data (5) . It is necessary to know how chemicals behave once they have been deposited in these sites, how they behave once they are released from the sites, and how they behave once they come into contact with humans. This complex array of information must be gathered for a large variety of different chemicals and for human populations that vary significantly in important characteristics. Considering the importance of local conditions, assessments for each site must be location specific and so must depend on emission, transport, and exposure data gathered at that particular site using the population at greatest risk.
To Froment et al. (6) . Major advances have been made in the application of gas chromatography/high resolution mass spectrometry to the identification and quantitation of N2,3-ethenoguanine (EG), the major promutagenic DNA adduct of vinyl chloride. Routine measurements of low fentomolar quantities of EG can now be made, and researchers have detected endogenous EG adducts in DNA from both human and animal liver samples (7) .
Immunohistochemical techniques have been developed using monoclonal antibodies that recognize adducts to aflatoxin B, (AFB1) (8) . AFBI, a potent liver carcinogen in animals, has been associated with increased incidence of hepatocellular carcinoma in Africa and Southeast Asia, especially in the presence of hepatitis infection. To better understand the role ofAFBI exposure in human cancer incidence, biological monitoring methods have been developed to quantitate exposure on an individual basis (9) . It is now possible to measure levels of the covalent adducts of AFB1 on DNA and protein quickly and effectively. Such (10) . Adduct levels also decline in a predictable manner upon cessation of smoking. Importantly, in studies of smokers using different types of tobacco, adduct levels dearly reflected metabolic capability for metabolizing the compound in a manner that also correlated with elevated risk of bladder cancer. Further, studies of newborn infants of smoking and nonsmoking mothers revealed the presence of 4-aminobiphenyl adducts in hemoglobin of the infants at levels reflective of the exposure history of the mothers. Thus, this approach provides a sensitive and accurate means of monitoring prenatal exposure to maternal smoking metabolites and demonstrates the technique's potential to monitor exposures to a wide variety of carcinogens.
Mutational Spectra
Analytical genetics is a component of genetic toxicology, which applies biotechnology to the molecular events of mutation. Understanding the mutational spectra of each chemical or physical exposure (the specificity and DNA context of a collection of mutations) is equivalent to identifying fingerprints that can in turn be used to identify the exposed populations.
A novel combination of technologies has been developed that would allow the detection and characterization of mutation in an exposed population without the need for either phenotypic selection, which limits the number of detectable sites, or DNA sequencing, which is extremely time consuming. The principles of the new approach developed by Coller and Thilly (11) 
Monitoring of Exposed Cohorts Air Polution
There is evidence of a link between environmental air pollution and cancer-related genetic damage in humans. Perera Cohort studies of children exposed to polychlorinated biphenyls (PCBs) in utero and in early life primarily through breastfeeding have indicated perturbations in growth and development (19) . Monitoring of human milk specimens has provided estimates of the prevalence of organochlorine exposures due to the lipophilic nature and biopersistence of the chemicals (20) .
Currently, the detection of the PCBs requires blood volumes in excess of 20 ml and thus necessitates venipuncture. This procedure is invasive, especially for infants and small children. A method has been developed by researchers that extracts the urine of infants from specially prepared cloth diapers and analyzes it for PCB congeners at the parts-per-trillion level. In a pilot study of five nursing infants, each had detectable levels of PCBs in the urine, and a significant correlation (r = 0.99) was observed between urinary PCB concentration and duration of breast-feeding. In the general population, it has been observed that there are large interindividual variations in a person's ability to respond to DNA-damaging agents. Researchers have noted greater than 5-fold variations in excision repair in the general population; among individuals who had a history of cancer among first degree relatives, there was a significant reduction in unscheduled DNA synthesis compared to individuals with no family history of cancer. In addition, interindividual variation in the activity of 06-alkyguanine-DNA-methyl transferase, an enzyme important in the removal of 06-deoxyguanine has been noted. The significance of these population differences in repair enzyme activities in relation to chemical exposure and cancer risk is yet to be determined (22) .
Perhaps the greatest advances in using molecular tools to unravel gene-environment interactions have been in studying the associations between exposure, polymorphisms in carcinogen-metabolizing genes, and cancer risk. The enzymes involved in carcinogen-metabolism fall into two broad categories: Phase I enzymes, which almost exclusively involve the cytochrome P450 gene superfamily but also include n-acetyl transferase and are involved in metabolic activation, and
Phase II enzymes such as glutathione S-transferases (GSTs), which are involved in detoxification reactions and are considered protective pathways. Recent advances in molecular DNA techniques have allowed for the identification of polymorphisms at the genetic level for several enzymes important in carcinogen metabolism. Bell et al. (23) have studied the associations between cigarette smoking, bladder cancer, and the glutathione S-transferase MI (GSTMJ) gene, which is polymorphic in the population and absent in approximately one-half of the Caucasian population. Their findings showed that persons who smoked and had no GSTMI were at greater risk for developing bladder cancer than those individuals who smoked and were GSTMI positive.
In an effort to combine molecular epidemiology and risk assessment, a number of investigators are pursuing the molecular characterization of genetic susceptibility of the human cytochrome P450 system as a potential biomonitor of chemical exposure and risk due to chemical exposure. A broad array of P450 genes has been characterized in both humans and animals; consequent to chemical exposures, these genes undergo changes in expression level or pattern in a variety of cell types. Genetic polymorphism in P450 expression may be an important determinant in differences in an individual's response to potential toxic exposures. Novel strategies have recently been developed for the specific and highly sensitive detection of P450 gene expression in a variety of human cells in culture and in primary cells isolated directly from human volunteers. These powerful assays, using PCR-based technology (24) and laser-activated fluorescence (25) It is obvious that there is a need to validate existing and promising biomarkers in tissues, individuals, and populations. A concerted effort should be focused on assessing inter-and intraindividual variability as well as inter-and intralaboratory variability (26) . Selection of laboratory measurement should be based on relevance to the end point and to the research hypothesis. Epidemiological study designs that incorporate biomarkers must take into account the methodological issues unique to their application. The future of biomonitoring human populations for disease and exposures lies in the discovery of new genes for chronic diseases and in the development of new biomarkers of exposure and susceptibility. The role of specimen repositories and laboratory networks is critical, and a mechanism of networking and funding mechanisms for such should be developed (27) . Researchers conducting studies of exposed individuals should bank any unused blood, urine, tissues, and cells for the promise of future discoveries. It is therefore very important that future research encourage cooperation, collaboration, and communication between multidisciplinary research teams (28) . To facilitate this process, regular interdisciplinary conferences could encourage interactions, improve the understanding of technical and logistic problems, and clarify data interpretation.
Prevention of human disease due to environmental contaminants can be accomplished by implementing strategies to monitor exposures and early health effects in human populations. New technologies entwined with diligent surveillance offer promise of further understanding of the role of environmental exposure in human disease.
